Literature DB >> 8340427

Characterization of the human aldose reductase gene promoter.

K Wang1, K M Bohren, K H Gabbay.   

Abstract

The promoter region of the human aldose reductase gene has been identified upstream of the translation start ATG codon. The promoter contains a TATA box, a CCAAT promoter element, and three Sp1 protein binding consensus sequences upstream of the capsite. A 640-base pair insert spanning +31 to -609 directs expression of the reporter gene chloramphenicol acetyltransferase in an orientation-specific manner in transfected Hep G2 cells. The promoter activity remained constant with deletions from base pairs -609 to -186. The TATA and the CCAAT consensus sequences show significant promoter activity, whereas the three Sp1 binding consensus sequences, individually, have no significant promoter activity. A GA-rich region (-186 to -146) contains two CGGAAA/G motifs, which show promoter activity and interaction with Hep G2 nuclear extract and GA-binding proteins (GABP alpha and GABP beta 1) as shown by mobility shift assays and DNase I footprinting. Similar cis-elements in herpes simplex virus type 1 interact with rat liver GABP and the viral VP16 protein to mediate the induction of immediate early viral genes. A GC-rich region (-87 to -31) is identified by mobility shift assay, and a consensus sequence of an androgen response element is present at -396 to -382. The human aldose reductase promoter, thus, has regulatory response elements that may be important during early development and puberty. These regulatory elements may play a significant role in the development of certain diabetic complications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340427

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis.

Authors:  R P Eaton; C Qualls; J Bicknell; W L Sibbitt; M K King; R H Griffey
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

2.  Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

Authors:  H L Rittner; V Hafner; P A Klimiuk; L I Szweda; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Characterization of the osmotic response element of the human aldose reductase gene promoter.

Authors:  B Ruepp; K M Bohren; K H Gabbay
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene.

Authors:  Rajash Pallai; Henry Simpkins; Jianli Chen; Hemant K Parekh
Journal:  Gene       Date:  2010-03-23       Impact factor: 3.688

Review 5.  Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.

Authors:  Ravichandran Ramasamy; Ira J Goldberg
Journal:  Circ Res       Date:  2010-05-14       Impact factor: 17.367

6.  Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.

Authors:  Ziwen Liu; Linlin Zhong; Paulette A Krishack; Sarah Robbins; Julia X Cao; Yupei Zhao; Stephen Chung; Deliang Cao
Journal:  Gene       Date:  2009-02-21       Impact factor: 3.688

7.  Cloning, genomic organization, and osmotic response of the aldose reductase gene.

Authors:  J D Ferraris; C K Williams; B M Martin; M B Burg; A García-Pérez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

8.  Four structurally distinct, non-DNA-binding subunits of human nuclear respiratory factor 2 share a conserved transcriptional activation domain.

Authors:  S Gugneja; J V Virbasius; R C Scarpulla
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 9.  The role of polyols in the pathophysiology of hypergalactosemia.

Authors:  G T Berry
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

10.  Aldose reductase (AC)n gene polymorphism in Iranian patients with type 2 diabetic microangiopathy; a case-control study.

Authors:  Mohammad Bagher Hashemi-Soteh; Ali Ahmadzadeh Amiri; Majid Reza Sheikh Rezaee; Amir Ahmadzadeh Amiri; Soleiman Olfat; Ahmad Ahmadzadeh Amiri
Journal:  Diabetol Int       Date:  2020-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.